[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intravenous infusion of investigative drug (adrenomedullin or placebo) will be started immediately after the allocation of the patient. The administration of the drug are maintained 72 hour and then intermittent administration (8 hours per day) are followed up to 10 days. The drug administration will be stop after withdrawal of oxygen administration.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 37, "treatment_name": "Adrenomedullin", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]